受限制的人类CD45异糖体形式作为功能性E-选择因子连接体,并划定造血成熟度
1Department of Translational Medicine and Translational Glycobiology Institute, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
The Journal of biological chemistry
|July 3, 2025
概括
新的CD45异型,称为异糖体,将E-selectin与不成熟的造血细胞结合. 一种特定的异糖型,CD45RABC-E,标记了急性髓性白血病 (AML) 细胞,将其与健康的干细胞和白细胞区分开来.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- CD45是一种在造血细胞上无处不在的糖蛋白,具有多种异型.
- CD45异构体的确切功能在很大程度上是未知的.
- CD45外显子 (A,B,C) 的替代拼接产生了在血液构造发育过程中受到限制的独特异构体.
研究的目的:
- 为了研究在人类造血细胞中特定的CD45异型的功能作用.
- 识别新的CD45糖形和它们作为生物标记物的潜力.
- 为了探索CD45异型在急性髓性白血病 (AML) 的表达.
主要方法:
- 在不成熟和成熟的人类造血细胞中分析CD45异型表达.
- 与E-selectin结合的CD45糖形体的表征.
- 在AML中识别和验证一种新的CD45异糖体 (CD45RABC-E)
- 在AML细胞中CD45RABC-E表达的比较与健康的造血干细胞和白细胞.
主要成果:
- 未成熟的造血细胞上的离散CD45异型体作为结合E-selectin的糖形体 (异糖形体) 起作用.
- "CD45RA",AML的标志物,识别了一种独特的异糖形式",CD45RABC-E",含有所有拼接外.
- CD45RABC-E由AML细胞上调调节,使其与成熟白细胞和造血干细胞区分开来.
- 耐治疗的AML表现出CD45RABC-E的高表达.
结论:
- CD45具有与特定的异糖形式相关的以前未知的功能.
- CD45RABC-E是一种新型异糖体,作为AML细胞的独特标记物.
- 这一发现区分了恶性AML细胞与基本健康的造血细胞,并为向治疗提供了潜在的潜力.
关键词:
这种CD15s是CD15s.CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45这种CD45异型是CD45异型.在E-selectin中选择对于E-selectin的结合物来说,这是一个很好的选择.它是同样形式的葡萄糖.斯莱克斯 (SLEX) 是一个西阿利尔·易斯XX 易斯翻译性葡萄糖生物学更多相关视频
15:32Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
Published on: August 5, 2011
32.8K
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
8.6K
相关概念视频
Selectins
3.4K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K
T Cell Activation and Clonal Selection
5.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
5.5K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Immunoglobulin-like Cell Adhesion Molecules
3.4K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.4K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
